Industry
AMES Technology
Total Trials
6
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
Failure Rate
33.3%
2 terminated/withdrawn out of 6 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
150%
3 of 2 completed trials have results
Key Signals
3 with results
Enrollment Performance
Analytics
N/A
3(50.0%)
Phase 1
3(50.0%)
6Total
N/A(3)
Phase 1(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT02765425Not ApplicableWithdrawn
Training the Brain with a Robotic Device for Balance Recovery
Role: collaborator
NCT00609115Not ApplicableCompleted
Sub-Acute Stroke Rehabilitation With AMES
Role: lead
NCT01116544Not ApplicableCompleted
Treatment of Chronic Stroke With AMES + EMG Biofeedback
Role: lead
NCT00847704Phase 1Terminated
Clinic-Based AMES Treatment of Stroke
Role: collaborator
NCT01169181Phase 1Unknown
AMES + Brain Stimulation
Role: lead
NCT01378637Phase 1Unknown
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
Role: lead
All 6 trials loaded